T2 Biosystems has received FDA clearance to update its T2Bacteria Panel, expanding its coverage of sepsis-causing pathogens and potentially leading ...
Monday.com's impressive Q4 results, including exceeding earnings and revenue expectations, did not prevent a stock slump. However, the company remains ...